BLOG

NK Cells vs T Cells: What the Difference Means for NK Cell Therapy

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

When people first read about immune cell therapy for cancer, they often meet two names again and again: NK cells and T cells. Both are white blood cells, and both take part in the body’s defense against abnormal cells. Yet they work in quite different ways. Understanding that difference can help you read information more critically and prepare better questions for your doctor. This article explains the basics in plain language, and it is intended for general education rather than as medical advice.

The short answer: two different kinds of immune cells

In simple terms, NK (natural killer) cells belong to the innate immune system, which is the body’s first line of defense. T cells belong to the adaptive immune system, which learns to recognize specific targets over time. NK cells can react to abnormal cells without needing prior training on a particular target, while T cells generally depend on recognizing specific markers presented on the surface of other cells.

Neither type is simply better than the other. They complement each other, and a healthy immune response usually involves both. For that reason, a doctor will not choose between them in the abstract. The question is always what is appropriate for the individual patient, based on the type and stage of cancer, previous treatment, and overall health.

How NK cells work

NK cells circulate in the blood and tissues, constantly checking the cells they meet. Healthy cells usually display signals that tell NK cells to hold back. When a cell is stressed, infected, or has become abnormal, those signals can be reduced or replaced by warning signals. NK cells weigh these messages and, when the balance tips, they can release molecules such as perforin that damage the abnormal cell.

This ability to act without waiting for instructions from other immune cells is why NK cells are described as part of innate immunity. It is also one reason they are discussed in the context of immune surveillance, the ongoing process by which the body detects and removes abnormal cells. It has been reported that NK cell activity can decline with age, stress, and the effects of cancer itself, which is part of the reasoning behind therapies that aim to support these cells.

How T cells work

T cells take a more targeted approach. Each T cell carries a receptor that fits a particular molecular marker, called an antigen. When a T cell encounters its matching antigen presented on another cell, it can become activated, multiply, and attack cells that carry that marker. Some T cells also form a memory of what they have met, which is the basis of long-lasting immunity after infections and vaccinations.

This precision is a strength, but it also has a limitation. Some cancer cells reduce the markers that T cells depend on, which can help them escape detection. Interestingly, cells that hide those markers can become more visible to NK cells, which is one reason researchers study the two cell types as partners rather than rivals. The details vary widely between cancer types, and many questions are still being investigated in clinical research.

What this means for NK cell therapy

NK cell therapy is a cancer immune cell therapy in which a patient’s own NK cells are collected from a standard blood draw, activated and expanded at a specialized cell processing facility, and then returned by intravenous infusion. The aim is to return NK cells that are greater in number and higher in activity, in order to support immune function that may have weakened. Because the cells come from the patient, the therapy is described as autologous, and the risk of rejection is considered low.

It is important to keep expectations realistic. Understanding how NK cells work does not mean that every patient will respond in the same way, and responses can differ from person to person. NK cell therapy is not a replacement for surgery, chemotherapy, or radiation therapy. In many cases it is considered as an additional option alongside standard treatment, and coordination with the medical institution providing that treatment is a sensible part of planning.

Questions to ask a doctor before you decide

Because NK cell therapy is a private, self-pay treatment in Japan and is not covered by public health insurance, it is worth preparing your questions in advance. A consultation is the place to confirm whether the therapy is suitable for your situation, and the answers should come from a physician who has reviewed your medical history. You may find the following topics useful to raise:

  • What is known, and what is still uncertain, about NK cell therapy for my type and stage of cancer?
  • How would the therapy fit with the standard treatment I am receiving or have received?
  • What temporary effects, such as fever or fatigue, can occur, and what other risks should I understand?
  • How many infusions are usually planned, over what period, and what is the total cost?
  • Who will coordinate with my current oncologist, and how will my progress be reviewed?

Good answers will acknowledge limits as well as possibilities. If any explanation sounds like a promise of a particular outcome, treat that as a reason to ask more questions.

Regulation and quality in Japan

In Japan, cell-based therapies of this kind are provided under the Act on the Safety of Regenerative Medicine. Under this system, a clinic submits a treatment plan that is reviewed by a certified committee and then submitted to the Ministry of Health, Labour and Welfare, and cells are processed at a licensed facility. A legal framework does not by itself tell you whether a therapy will help you, but it does give you concrete things to ask about, such as the plan under which treatment is offered and how cell quality is managed.

Consulting in Osaka as an international patient

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka and offers NK cell therapy as a self-pay treatment. Information pages are available in several languages, which can be helpful if you live in Japan as a foreign resident or are considering traveling for medical care. Whichever route you take, bring your diagnosis records, recent test results, and a list of your current treatments, so the doctor can discuss options with an accurate picture of your situation.

To sum up, NK cells and T cells are different tools in the same immune toolbox. NK cells act quickly as part of innate immunity, while T cells provide targeted and remembered responses. NK cell therapy builds on the first of these ideas, but whether it is appropriate for you can only be decided in a medical consultation that covers eligibility, risks, side effects, and cost.

Learn more about NK Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact